Antiphospholipid syndrome in cardiac surgery—an underestimated coagulation disorder?☆
Author(s) -
Parwis Massoudy,
Sürreya M. Cetin,
Matthias Thielmann,
Peter Kienbaum,
Jarowit Piotrowski,
G. Marggraf,
Christof Specker,
Heinz Jakob
Publication year - 2005
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2004.12.062
Subject(s) - medicine , surgery , perioperative , antiphospholipid syndrome , patent foramen ovale , cardiac surgery , cardiopulmonary bypass , thrombus , mitral valve replacement , cardiology , mitral valve , thrombosis , percutaneous
Antiphospholipid syndrome (APS) is a rare coagulation disorder associated with recurrent arterial and venous thrombotic events. We analysed our experience with five APS patients who underwent cardiac surgery. In three of them the diagnosis of APS had been established before surgery, two patients were diagnosed after surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom